Sponsored by VMG Health | info@vmghealth.com | 214.369.4888

CHOP signs preclinical research collaboration with NeuroVive

The Children's Hospital of Philadelphia signed a preclinical research agreement with Lund, Sweden-based NeuroVive Pharmaceutical AB to advance research and development in models of mitochondrial complex I dysfunction.

The financial terms of the agreement were not disclosed.

"We feel fortunate to be able to initiate this collaboration with a well-recognized institution like CHOP…This is an important step in further advancing and strengthening our [mitochondrial research] program, as well as in the development of novel treatment opportunities for people with mitochondrial medicine disorders," said Magnus Hansson, CMO of NeuroVive.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars